IVIATIn Vivo Induced Antigen Technology
References in periodicals archive ?
Oragenics' research in the field of probiotic oral care has led to a pipeline of products ranging from novel anti-infectives to this IVIAT platform technology.
from Laval University in Canada and is a co-inventor of ONI BioPharma's IVIAT platform technology that enables the rapid identification of novel and potentially important gene targets associated with the natural onset and progression of human infections.
IVIAT can quickly and easily identify in vivo induced genes in human infections without the use of animal models, facilitating the discovery of new targets for the development of vaccines, antimicrobials and diagnostics.